Boston Commerce Schedules Board Meeting on 15th Nov'26 to Consider Q1 and Q2 Results
Boston Bio Systems Ltd 路 Intimation 路 15 Nov 2026, 5:30 am
Boston Commerce Schedules Board Meeting on 15th Nov'26 to Consider Q1 and Q2 Results Boston Commerce Limited has scheduled a Board of Directors meeting on 15th Nov'26 to consider and approve the unaudited financial results and limited review reports for both the quarter ended 30th Jun'26 and the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in the company's securities remains closed under SEBI Insider Trading Regulations until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Boston Bio Systems Ltd
- Intimation Regarding Change in Domain Name of Website of the Company 路 06 Oct 2026
- Submission of Voting Results of AGM held on 30th September 2026 路 06 Oct 2026
- Submission of Scrutinizer''s Report of AGM held on 30th September 2026. 路 05 Oct 2026
- Outcome of Annual General Meeting (AGM) held on September 30th 2026 路 30 Sept 2026
- Letter to Shareholder in respect of 31st Annual General Meeting of the Company 路 12 Sept 2026
- Annual Report for FY 2025-26 路 12 Sept 2026
- Appointment of Statutory Auditor 路 12 Sept 2026
- Outcome of Board Meeting held on 11th September, 2026 路 12 Sept 2026
